This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Preliminary Studies

ROBERT P. BURNS, M.D.; RICHARD BEIGHLE, B.S.

Arch Ophthalmol. 1960;64(5):712-723.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Healing of surgical wounds, especially those of cataract and retinal detachment operations, is an important current topic in ophthalmology. Since collagen formation is a vital phase of wound healing, recent data indicating that carrageenin is a powerful stimulus to production of collagen makes it of interest to study the effect of this compound on ocular tissues.

Carrageenin is a refined water-soluble hydrocolloid extracted from a seaplant, Irish moss (Chondrus crispus). It is a negatively charged polymer composed of two major fractions, of approximately equal proportions, lambda carrageenin (Fig. 1) and kappa carrageenin (Fig. 2). Both components are polydisperse, are composed of sulfated D-galactose units and have molecular weights in the range of 100,000 to 500,000. Lambda carrageenin is composed almost entirely of these units linked through the 1-3 positions and kappa carrageenin contains one unit of anhydro-D-galactose for approximately every 1.2 units of D-galactose. They form a highly viscous solution . . . [Full Text PDF of this Article]

Author Affiliations
Portland, Ore.

From the John E. Weeks Institute for the Advance of Ophthalmology, University of Oregon Medical School.

Footnotes
Submitted for publication May 11, 1960.

Aided in part by a grant from the Schering Corporation, Bloomfield, New Jersey.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?